Company facts
Early-stage
- Founded
- 2015
- Employees
- 2
- Headquarters
- United States
About
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.